Company Filing History:
Years Active: 2019-2022
Title: Grant Hogg: Innovator in Non-Invasive Prenatal Diagnostics
Introduction
Grant Hogg is a prominent inventor based in San Diego, California. He has made significant contributions to the field of non-invasive prenatal diagnostics, holding three patents that showcase his innovative approaches to genetic assessment.
Latest Patents
Hogg's latest patents include groundbreaking methods and processes for non-invasive assessment of genetic variations. One of his notable inventions involves determining fetal ploidy through nucleic acid sequence reads obtained from circulating cell-free nucleic acid in the blood of pregnant females. This method allows for the determination of fetal ploidy based on genomic section levels and the fraction of fetal nucleic acid present in a test sample. Another significant patent focuses on methylation-based enrichment of fetal nucleic acid from maternal samples. This invention utilizes differentially methylated genomic regions to separate and enrich fetal nucleic acid, which is particularly useful for non-invasive prenatal diagnostics, including the detection of chromosomal aneuploidies.
Career Highlights
Grant Hogg is currently associated with Sequenom, Inc., a company known for its advancements in genetic testing and diagnostics. His work has positioned him as a key figure in the development of non-invasive methods that enhance prenatal care.
Collaborations
Hogg collaborates with notable colleagues, including John Allen Tynan and Cosmin Deciu, who contribute to the innovative research and development efforts at Sequenom, Inc.
Conclusion
Grant Hogg's contributions to non-invasive prenatal diagnostics through his patents and collaborative efforts highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in genetic testing and prenatal care.